Axogen (AXGN) Form 144: Insider to Sell 7,620 Shares
Axogen, Inc. insider filed a Form 144 notifying a proposed sale of 7,620 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $136,169.40.
Rhea-AI Filing Summary
Axogen, Inc. insider filed a Form 144 notifying a proposed sale of 7,620 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $136,169.40. The filing lists the number of shares outstanding as 46,012,574 and an approximate sale date of 10/02/2025 on NASDAQ. The securities were acquired as Restricted Stock Units on 09/01/2024 from the issuer and the filing reports "Nothing to Report" for sales in the prior three months. The Form 144 includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider submitted a routine Form 144 to sell 7,620 shares via Morgan Stanley Smith Barney.
The filing documents a proposed sale of 7,620 common shares with an aggregate market value of $136,169.40 and lists 46,012,574 shares outstanding. The shares were acquired as Restricted Stock Units on 09/01/2024.
The notice states the planned sale date as 10/02/2025 on NASDAQ and reports no sales in the prior three months. This is a procedural disclosure required under Rule 144; the filing contains the signer’s representation about not possessing undisclosed material adverse information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the AXGN Form 144 disclose?
When is the planned sale date on the AXGN Form 144?
Does the filing report any sales in the prior three months for the selling person?
Which broker is handling the proposed sale in the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.